Form 4 Tracker
Carole Ho

Director · 1 filing · Latest: Jun 5, 2026

Royalty Pharma plc
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
BEAM
CAROLE HO—Apr 14, 2026
Proposed Sale
$30.7387,784$2.7M—
DNLI
CAROLE HO—Feb 5, 2026
Proposed Sale
$20.2939,490$801.4K—
DNLI
CAROLE HO—Feb 4, 2026
Proposed Sale
$21.18150,000$3.2M—
DNLI
CAROLE HO—Feb 3, 2026
Proposed Sale
$22.16150,000$3.3M—
DNLI
Ho Carole—Jan 6, 2026
Proposed Sale
$16.5017,218$284.1K—
DNLI
CAROLE HO—Dec 4, 2025
Proposed Sale
$19.001,882$35.8K—
DNLI
CAROLE HO—Aug 13, 2025
Proposed Sale
$13.22806$10.7K—
DNLI
Ho Carole—Aug 12, 2025
Proposed Sale
$13.582,937$39.9K—
DNLI
Ho Carole—Jan 7, 2025
Proposed Sale
$20.812,907$60.5K—
DNLI
Ho Carole—Jan 6, 2025
Proposed Sale
$20.2212,255$247.8K—
DNLI
CAROLE HO—Aug 21, 2024
Proposed Sale
$23.6520,005$473.1K—